tryptoline has been researched along with Blood Clot in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, L; Peng, S; Wang, Y; Yao, K; Zhang, X; Zhao, M; Zheng, M | 1 |
Baudy-Floc'h, M; Bi, L; Bi, W; Cai, J; Liu, S | 1 |
2 other study(ies) available for tryptoline and Blood Clot
Article | Year |
---|---|
A class of oral N-[(1S,3S)-1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carbonyl]- N'-(amino-acid-acyl)hydrazine: discovery, synthesis, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and 3D QSAR analysis.
Topics: Administration, Oral; Amino Acids; Animals; Carbolines; Dose-Response Relationship, Drug; Drug Discovery; Fibrinolytic Agents; Humans; Hydrazines; Inhibitory Concentration 50; Male; Models, Animal; Molecular Dynamics Simulation; Platelet Aggregation; Quantitative Structure-Activity Relationship; Rats; Rats, Wistar; Swine; Thrombosis | 2011 |
Design, synthesis and cardioprotective effect of a new class of dual-acting agents: phenolic tetrahydro-beta-carboline RGD peptidomimetic conjugates.
Topics: Animals; Carbolines; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Fibrinolytic Agents; Free Radical Scavengers; Molecular Structure; Oligopeptides; PC12 Cells; Phenol; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Thrombosis | 2007 |